MLchartDataset catalogue

Patent · US11969452B2 · B2 · US

Processes, methods and rationale for manufacturing pre-probiotic dietary supplements aimed at protecting the human body from the harmful effects of electromagnetic radiations through quantum entanglement of DNA repair genes elicited by natural superluminal particles inducing photosynthesis via Cherenkov effect

(11) Publication number
US11969452B2
(21) Application number
17/343,501
(22) Filing date
2021-06-09
(30) Priority date
2021-06-09
(43) Publication date
2024-04-30
(45) Date of grant
2024-04-30
(51) IPC
A61K 35/748; A61K 36/11; A61K 9/00; A61K 9/06; A61P 39/00; A61K 9/19
(52) CPC
  • A61K Preparations for medical, dental or toiletry purposes: 36/11, 35/748, 47/02, 47/26, 47/46, 9/0014, 9/06, 9/19, 9/4858
  • A61P Specific therapeutic activity of chemical compounds or medicinal preparations: 39/00
(72) Inventors
Marco Ruggiero
(54) Title
Processes, methods and rationale for manufacturing pre-probiotic dietary supplements aimed at protecting the human body from the harmful effects of electromagnetic radiations through quantum entanglement of DNA repair genes elicited by natural superluminal particles inducing photosynthesis via Cherenkov effect
(57) Abstract

This invention is a process to manufacture a probiotic food supplement that can protect the human body from the harmful effects of ionizing and non-ionizing electromagnetic radiations such as gamma and X rays, as well as radio waves.

Full text
View on Google Patents

Claims (1)

  1. A process to manufacture a lyophilized probiotic powder composition aimed at protection from harmful effects of electromagnetic radiations, comprising the steps of: providing a medium for the growth of probiotic microbes constituted by carbonated radioactive mineral water whose radioactivity is due to 226 Radium at 152 mBq L −1 and 238 Uranium at 217.7 mBq L −1, comprising: 40 g/L Equisetum arvense, 40 g/L white sugar, 15 ml/L lemon juice, and 10 ml/L apple cider vinegar; inoculating the medium with Arthrospira platensis at 45 g/L and 10 mg/L of a probiotic mixture comprising: Lactobacillus paracasei, Lactobacillus casei, Lactobacillus helveticus, Lactobacillus kefiranofaciens, Lactobacillus plantarum, Lactobacillus gallinarum, Lactobacillus delbrueckii, Lactobacillus rhamnosus, Lactobacillus salivarium, Lactobacillus acidophilus, Lactobacillus farraginis, Lactobacillus antri, Lactococcus lactis, Lactococcus diacetylactis, Lactococcus cremoris, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium lactis, and Bifidobacterium longum; cultivating Arthrospira platensis and the probiotic mixture in the medium comprising radioactive carbonated mineral water with Equisetum arvense at a temperature range of 36° C. to 39° C. for 48 h, with stirring at 0, 12, 24, and 36 h, to produce a probiotic composition; harvesting the probiotic composition from the medium; lyophilizing the probiotic composition to produce a lyophilized probiotic powder; and encapsulating the lyophilized probiotic powder.

Description

Not applicable

Not applicable

A portion of the disclosure of this patent document may contain material which is subject to copyright protection. This patent document may show and/or describe matter which is or mat become trade dress of the owner. The copyright and trade dress owner has no objection to the facsimile reproduction by any one of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or records, but otherwise reserves all copyrights and trade dress rights whatsoever.

This invention relates to the processes, methods and rationale to manufacture pre-probiotic products that have the goal of protecting the human body from the harmful effects of electromagnetic radiations. These include ionizing radiations such as gamma- or X-rays as well as non-ionizing radiations such as radio waves such as those used for mobile telecommunication comprising the fifth generation technology standard for cellular networks, also known as 5G.

Ruggiero M (July 2020: cited as reference 1 on Information Disclosure Statement, form PTO/SB/08b) Experimental evidence for the role of natural radioactivity in influencing viability of commensal microorganisms. bioRxiv preprint. doi: https://doi.org/10.1101/2020.07.21.214676. Posted on Jul. 22, 2020. Total pages 1-32. Year 2020. This version posted on Jul.

Record as JSON
{
  "publication_number": "US11969452B2",
  "country": "US",
  "kind": "B2",
  "title": "Processes, methods and rationale for manufacturing pre-probiotic dietary supplements aimed at protecting the human body from the harmful effects of electromagnetic radiations through quantum entanglement of DNA repair genes elicited by natural superluminal particles inducing photosynthesis via Cherenkov effect",
  "abstract": "This invention is a process to manufacture a probiotic food supplement that can protect the human body from the harmful effects of ionizing and non-ionizing electromagnetic radiations such as gamma and X rays, as well as radio waves.",
  "claims": [
    "1. A process to manufacture a lyophilized probiotic powder composition aimed at protection from harmful effects of electromagnetic radiations, comprising the steps of: providing a medium for the growth of probiotic microbes constituted by carbonated radioactive mineral water whose radioactivity is due to 226 Radium at 152 mBq L −1 and 238 Uranium at 217.7 mBq L −1, comprising: 40 g/L Equisetum arvense, 40 g/L white sugar, 15 ml/L lemon juice, and 10 ml/L apple cider vinegar; inoculating the medium with Arthrospira platensis at 45 g/L and 10 mg/L of a probiotic mixture comprising: Lactobacillus paracasei, Lactobacillus casei, Lactobacillus helveticus, Lactobacillus kefiranofaciens, Lactobacillus plantarum, Lactobacillus gallinarum, Lactobacillus delbrueckii, Lactobacillus rhamnosus, Lactobacillus salivarium, Lactobacillus acidophilus, Lactobacillus farraginis, Lactobacillus antri, Lactococcus lactis, Lactococcus diacetylactis, Lactococcus cremoris, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium lactis, and Bifidobacterium longum; cultivating Arthrospira platensis and the probiotic mixture in the medium comprising radioactive carbonated mineral water with Equisetum arvense at a temperature range of 36° C. to 39° C. for 48 h, with stirring at 0, 12, 24, and 36 h, to produce a probiotic composition; harvesting the probiotic composition from the medium; lyophilizing the probiotic composition to produce a lyophilized probiotic powder; and encapsulating the lyophilized probiotic powder."
  ],
  "description_excerpt": "Not applicable\n\nNot applicable\n\nA portion of the disclosure of this patent document may contain material which is subject to copyright protection. This patent document may show and/or describe matter which is or mat become trade dress of the owner. The copyright and trade dress owner has no objection to the facsimile reproduction by any one of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or records, but otherwise reserves all copyrights and trade dress rights whatsoever.\n\nThis invention relates to the processes, methods and rationale to manufacture pre-probiotic products that have the goal of protecting the human body from the harmful effects of electromagnetic radiations. These include ionizing radiations such as gamma- or X-rays as well as non-ionizing radiations such as radio waves such as those used for mobile telecommunication comprising the fifth generation technology standard for cellular networks, also known as 5G.\n\nRuggiero M (July 2020: cited as reference 1 on Information Disclosure Statement, form PTO/SB/08b) Experimental evidence for the role of natural radioactivity in influencing viability of commensal microorganisms. bioRxiv preprint. doi: https://doi.org/10.1101/2020.07.21.214676. Posted on Jul. 22, 2020. Total pages 1-32. Year 2020. This version posted on Jul.",
  "cpc": [
    "A61K 36/11",
    "A61K 35/748",
    "A61K 47/02",
    "A61K 47/26",
    "A61K 47/46",
    "A61K 9/0014",
    "A61K 9/06",
    "A61K 9/19",
    "A61K 9/4858",
    "A61P 39/00"
  ],
  "ipc": [
    "A61K 35/748",
    "A61K 36/11",
    "A61K 9/00",
    "A61K 9/06",
    "A61P 39/00",
    "A61K 9/19"
  ],
  "inventors": [
    "Marco Ruggiero"
  ],
  "filing_date": "2021-06-09",
  "publication_date": "2024-04-30",
  "grant_date": "2024-04-30",
  "priority_date": "2021-06-09",
  "application_number": "US-202117343501-A",
  "family_id": "84490862",
  "cited_by_count": 2
}

Record 501 of 8,000 in Patents full text (MLC-0201). Request the full dataset.